Increasing awareness amongst people for early treatment of disease is set to propel the growth of the Gouty Arthritis market

HYDERABAD, TELANGANA, INDIA, February 10, 2023/EINPresswire.com/ -- The Gouty Arthritis Market size is $ 2.89 billion in 2019, growing at a CAGR of 6.4% during the forecast period 2020-2025. It is a form of inflammatory arthritis which can cause extreme pain, joint swelling, warmth, and redness in the foot, knee, elbow, wrist, and fingertips. Gouty arthritis is caused by a condition known as hyperuricemia. It is caused owing to a combination of genetic factors and diet. Uric acid is found in foods (containing purine metabolism) in the form of crystals in a joint collected in the soft tissue of the joint, causing swelling, redness, and warmth. Low-dose aspirin (acetylsalicylic acid) precipitates gout attacks in people who have high levels of urate in the blood.

Click here to browse the complete report summary:
https://www.industryarc.com/Report/17393/gouty-arthritis-market.html

Key Takeaways

1. Increasing awareness amongst people for early treatment of disease is set to propel the growth of the market.

2. Increasing prevalence of obesity is the driving factor for the growth of the Gouty Arthritis market.

3. Increased geriatric population with modernized routine disorders aiding growth towards the market.

4. Europe region is estimated to record the fastest growth rate during the forecast period 2020-2025.

Interested in knowing more relevant information? Click here:
https://www.industryarc.com/pdfdownload.php?id=17393

Segmental Analysis:

1. The Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) segment dominated the Gouty Arthritis Market in terms of revenue and is estimated to grow at a CAGR of 5.8%. Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) are the drugs most widely used to treat the pain and inflammation of acute gout attacks in patients. It helps in reducing inflammation and the severe pain caused owing to joint swelling. It works by work by preventing an enzyme called cyclooxygenase (COX) from making hormone-like chemicals prostaglandins abetting towards the market’s growth.

2. The North America region dominated Gouty Arthritis Market in terms of revenue with a market share of 39% owing towards owing to the presence of established payers and an increase in the number of Gouty Arthritis patients in the region. This growth can be attributed to the increasing research & development initiatives and government support for the improvement of the healthcare sector. The U.S. holds the biggest market for gout disease treatment, followed by Canada in North America.

Competitive landscape:

The top 5 players in the Gouty Arthritis industry are:

1. AstraZeneca plc.
2. Takeda Pharmaceutical Company Ltd
3. Novartis AG
4. Savient Pharmaceuticals
5. GlaxoSmithKline plc

Click on the following link to buy the Gouty Arthritis Market Report:
https://www.industryarc.com/reports/request-quote?id=17393

Why Choose IndustryARC?

IndustryARC is one of the leading market research and consulting firms in the world. It produces over 500 unique market reports annually. If you are looking for a detailed overview of a particular market, you can simply connect with the team at IndustryARC. You can not only buy your preferred market report from the website but also get personalized assistance on specific reports.

Contact Us:

Mr. Venkat Reddy
IndustryARC
Email: venkat@industryarc.com, sales@industryarc.com
USA: (+1) 970-236-3677, (+1) 815-656-4596
IND: (+91) 40-485-49062

Venkat Reddy
IndustryARC
+ +1 614-588-8538
venkat@industryarc.com
Visit us on social media:
Facebook
Twitter
LinkedIn

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.